Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03832010 · ClinicalTrials.gov registry record · Phase 4

Steroid-reducing Effects of Crisaborole

A Phase 4 study of Atopic Dermatitis and Eczema, sponsored by Johns Hopkins University.

Completed
Registry status
Phase 4
Development phase
24
Enrollment target
1
Study location

NCT03832010 is a Phase 4 study of Atopic Dermatitis and Eczema that has completed, run by Johns Hopkins University. The registered enrollment target is 24 participants, below the 609-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03832010, a Phase 4 study of Atopic Dermatitis and Eczema, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
Phase 4
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

Atopic dermatitis, or eczema, is a chronic skin condition affecting many children. Crisaborole is a non-steroid topical medication which is FDA approved for children aged 2 and older for eczema. This research study seeks to investigate whether crisaborole reduces topical steroid use in children with atopic dermatitis.

Conditions Studied

Atopic Dermatitis Eczema

Interventions

  • DRUG Hydrocortisone Ointment
  • DRUG Crisaborole
  • DRUG Triamcinolone ointment
  • DRUG Aquaphor

Study Locations (1)

Maryland

  • Johns Hopkins Hospital - Baltimore

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2019-12-17
Est. Completion 2024-02-16
Phase Phase 4

Sponsor

Johns Hopkins University

1,448 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03832010

The ClinicalTrials.gov registry entry for NCT03832010 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 609-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (96% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Atopic Dermatitis appearing as the primary indexed condition, and to 4 interventions - of which Hydrocortisone Ointment is the first listed.

NCT03832010 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT03832010 about?

NCT03832010 is a clinical study titled "Steroid-reducing Effects of Crisaborole". Atopic dermatitis, or eczema, is a chronic skin condition affecting many children. Crisaborole is a non-steroid topical medication which is FDA approved for children aged 2 and older for eczema. This research study seeks to investigate whether crisaborole reduces topical steroid use in children with...

What is the current status of trial NCT03832010?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2019-12-17. Estimated completion is 2024-02-16.

What conditions does trial NCT03832010 study?

This clinical trial studies the following conditions: Atopic Dermatitis, Eczema.

What interventions are being tested in trial NCT03832010?

The interventions under investigation include: Hydrocortisone Ointment (DRUG), Crisaborole (DRUG), Triamcinolone ointment (DRUG), Aquaphor (DRUG).

Who is sponsoring clinical trial NCT03832010?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03832010 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atopic Dermatitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Atopic Dermatitis

All registered trials for this condition

Eczema

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.